(415) 599-9884
Contact

GLP-1 Medications (Ozempic and Wegovy) and Eating Disorders

Posted on: November 17th, 2026 by Our Team

GLP-1 medications, including Ozempic and Wegovy, have become increasingly popular for managing diabetes and helping people lose weight. These medications work by reducing appetite, increasing feelings of fullness, and changing how the body responds to food. While they can provide important medical benefits, their effects on eating behaviors raise concerns for people who struggle with eating disorders.

For individuals with an eating disorder or a history of disordered eating, GLP-1 medications may present additional challenges. They can inadvertently reinforce unhealthy attitudes toward food, make eating disorder symptoms more difficult to recognize, and interfere with recovery. Understanding these potential risks is important before starting treatment.

What are GLP-1 medications?

GLP-1 medications mimic a hormone naturally produced by the body that helps regulate blood sugar, appetite, and digestion. They slow the movement of food through the stomach and influence signals in the brain that control hunger and fullness.

Ozempic and Wegovy both contain semaglutide, although they are prescribed for different medical purposes. Ozempic is primarily used to treat type 2 diabetes, while Wegovy is prescribed for weight management in eligible patients and certain other medical conditions.

By reducing hunger and helping people feel full sooner, these medications often lead to smaller portions and decreased food intake. Some individuals also experience fewer persistent thoughts about food, sometimes referred to as “food noise.”

However, for someone with an eating disorder, these changes can complicate an already difficult relationship with food.

How can GLP-1 medications affect eating disorders?

Eating disorders are serious conditions involving unhealthy thoughts, emotions, and behaviors surrounding food, eating, body weight, or appearance. Because GLP-1 medications affect appetite and eating patterns, their impact may vary depending on the type of eating disorder.

Anorexia nervosa

Anorexia nervosa involves inadequate food intake, often accompanied by an intense fear of gaining weight and a distorted perception of body weight or shape. GLP-1’s can unintentionally exacerbate an eating disorder like anorexia.

Bulimia nervosa

Bulimia nervosa involves recurring episodes of binge eating followed by behaviors intended to compensate for eating, such as vomiting, fasting, or excessive exercise.

Although GLP-1 medications may improve binge eating but the nausea and vomiting caused by medication may complicate the assessment of someone who has a history of purging.

Binge eating disorder

Binge eating disorder involves repeated episodes of consuming unusually large amounts of food while feeling unable to control eating.

GLP-1 medications may help reduce binge eating episodes in some individuals. However, improvements in appetite control do not necessarily resolve the emotional and psychological factors contributing to the disorder.

Someone may experience fewer binge eating episodes while continuing to struggle with shame, anxiety surrounding food, or negative body image. These concerns may still require specialized treatment.

How can GLP-1 medications make eating disorder recovery more difficult?

Recovering from an eating disorder involves more than changing eating habits or body weight. Treatment focuses on restoring physical and emotional health, developing consistent eating patterns, challenging harmful beliefs, and building a healthier relationship with food.

GLP-1 medications can complicate this process in several ways.

  • Reinforcing disordered eating thoughts and behaviors – People with eating disorders often develop rigid beliefs about food, body weight, and the importance of controlling their eating. The appetite suppression and weight loss associated with GLP-1 medications may unintentionally validate these beliefs. For example, someone who associates eating less with personal success may interpret the medication’s effects as confirmation that their existing attitudes toward food are appropriate. This can make it harder to recognize unhealthy patterns, challenge deeply established beliefs and develop greater flexibility around eating.
  • Masking the symptoms and severity of eating disorders – Some effects of GLP-1 medications overlap with symptoms commonly associated with eating disorders. Changes in appetite, meal frequency, food intake, and body weight may be attributed entirely to medication rather than recognized as potential signs of an eating disorder. For example, a person who begins avoiding meals or experiencing significant nutritional difficulties may assume these changes are simply expected medication effects. This overlap can make it harder for patients, family members, and healthcare providers to recognize worsening symptoms. It may also delay appropriate treatment, particularly when changes in eating behavior are assessed primarily through the lens of medication-related weight loss. An eating disorder can be medically serious at any body weight, making careful evaluation of both physical and psychological symptoms essential.
  • Interfering with eating disorder treatment goals – Eating disorder treatment often includes establishing regular meals, meeting nutritional needs, reducing anxiety around eating, and learning to respond appropriately to hunger and fullness. GLP-1 medications can complicate these goals by causing early fullness, nausea, digestive discomfort, or reduced interest in food. Someone following a structured nutritional plan, for example, may find it difficult to complete meals because they feel full after a few bites. Others may have trouble distinguishing their body’s usual hunger signals from medication-related changes.

These effects can create obstacles to nutritional rehabilitation and make it more difficult to achieve important recovery milestones.

Can GLP-1 medications trigger an eating disorder relapse?

People who have recovered from an eating disorder may remain vulnerable to a return of unhealthy thoughts or behaviors, particularly during periods of physical or emotional change.

For some individuals, the experience of losing weight or paying closer attention to body measurements may bring back concerns that were previously addressed during treatment.

Others may notice renewed anxiety around eating, increased body dissatisfaction, or a return to familiar patterns of thinking about food.

Although taking a GLP-1 medication does not necessarily cause a relapse, these changes warrant attention. Recognizing early warning signs and discussing them with a healthcare professional can help prevent difficulties from escalating.

Should someone with an eating disorder take GLP-1 medications?

An eating disorder diagnosis or history does not automatically rule out every GLP-1 medication. However, the potential benefits and risks should be carefully evaluated, particularly for individuals with active eating disorders or those currently undergoing treatment.

Before starting these medications, patients should tell their prescribing physician about any history of anorexia, bulimia, binge eating disorder, or other eating-related difficulties.

When treatment is appropriate, coordination among the prescribing physician, eating disorder therapist, and registered dietitian can help ensure that medical care supports the person’s overall health and recovery goals.

GLP-1 medications can provide important benefits for certain medical conditions, but they are not substitutes for comprehensive eating disorder treatment.

Recovery requires addressing the thoughts, emotions, and behaviors that contribute to an unhealthy relationship with food while supporting adequate nutrition and physical well-being.

If you are struggling with an eating disorder, have a history of disordered eating, or are concerned about how GLP-1 medications may be affecting your relationship with food, professional support can help. At HealMarin, Arin Bass, LMFT, provides compassionate, individualized therapy to help patients address unhealthy eating behaviors, improve body image, and develop a healthier relationship with food. Schedule a consultation today to discuss your concerns and take a positive step toward lasting recovery.

At a Glance

Arin Bass, LMFT

  • Licensed Marriage and Family Therapist Marin County
  • 20 years of experience
  • IAEDP SF Bay Area Chapter Hospitality Chair
  • Eating Disorder Recovery Support (EDRS) Sponsorship Chair
  • Learn more

Join Our Email Newsletter